S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
ASX:HSO

Healthscope Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume38.30 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield2.86%
BetaN/A

Receive HSO News and Ratings via Email

Sign-up to receive the latest news and ratings for Healthscope and its competitors with MarketBeat's FREE daily newsletter.


About Healthscope

Healthscope Limited provides healthcare services in Australia and New Zealand. The company operates through Hospitals Australia and Pathology New Zealand segments. It operates 43 private hospitals, including 30 acute hospitals, 7 mental health hospitals, and 6 rehabilitation hospitals with approximately 5,000 inpatient beds. The company also provides human pathology services under the Labtests, Southern Community Laboratories, and Northland Pathology brands; and veterinary and analytical pathology services under the Gribbles brand. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. and changed its name to Healthscope Limited in July 2014. Healthscope Limited was founded in 1985 and is headquartered in Melbourne, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Hospitals
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.17 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Healthscope (ASX:HSO) Frequently Asked Questions

What stocks does MarketBeat like better than Healthscope?

Wall Street analysts have given Healthscope a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Healthscope wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Healthscope's earnings last quarter?

Healthscope Ltd (ASX:HSO) released its quarterly earnings results on Thursday, February, 14th. The company reported $0.04 earnings per share for the quarter.
View Healthscope's earnings history
.

Is Healthscope a good dividend stock?

Healthscope pays an annual dividend of A$0.07 per share and currently has a dividend yield of 2.86%.
View Healthscope's dividend history.

Who are Healthscope's key executives?

Healthscope's management team includes the following people:
  • Mr. Gordon Scott Ballantyne, MD, CEO & Director (Age 54)
  • Mr. Michael Sammells, Chief Financial Officer
  • Mr. Mark Briscoe, Gen. Mang. of Operations
  • Mr. David Shirer, Gen. Mang. of Investor Relations
  • Ms. Ingrid A. Player, Group Exec. of Legal, Governance & Sustainability, Gen. Counsel and Sec. (Age 46)

Who are some of Healthscope's key competitors?

What other stocks do shareholders of Healthscope own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthscope investors own include UBS ETRACS CMCI Energy Total Return ETN (UBN), Primary Health Care (PRY) and Fortescue Metals Group (FMG).

What is Healthscope's stock symbol?

Healthscope trades on the ASX under the ticker symbol "HSO."

How much money does Healthscope make?

Healthscope has a market capitalization of $0.00.

How many employees does Healthscope have?

Healthscope employs 17,100 workers across the globe.

What is Healthscope's official website?

The official website for Healthscope is www.healthscope.com.au.

Where are Healthscope's headquarters?

How can I contact Healthscope?

Healthscope's mailing address is Level 1, 312 St. Kilda Road, MELBOURNE, VIC 3001, Australia. The company can be reached via phone at +61-3-99267500.


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.